tirzepatide/b12 Injectable (68mg/8mg) Eli Lilly Issues Warning Regarding
Description
Notably, although the Glp1r knockout mice show normal testicular morphology, their sperm concentration was higher than the control mice
The $50 billion elephant in the room is whether there will be enforcement by the FDA against compounders alleging violations of the FDCA prohibition on compounding products that are essentially a copy of FDA-approved products now that the branded GLP-1 products are no longer in shortage
This affects injection volume and makes switching between pharmacies more complex
338 adults with obesity without T2D
Novo has had successes: courts issued 44 permanent injunctions against certain compounders
In trials, participants saw an average weight reduction of 20.9% with the highest dose
